SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs admission of an affair and Nvidias independent board investigation are drawing attention amid reports that the woman was a suspected Chinese intelligence asset. Traders are split over possible governance and national-security fallout, including whether Huang could leave the CEO role, while others view it as personal news that does not change Nvidias business; any compromise of company secrets remains unconfirmed.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.16094256 USD and is down -1.49 over the last 24 hours. It is currently trading on 1894 active market(s) with $1,342,393,155.38 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRPs sharp slide alongside broader crypto weakness is driving discussion, with bearish traders warning of further losses while holders describe the pullback as a buying opportunity. Some traders also blame election-related uncertainty and fears that crypto legislation could stall, though those explanations remain speculative.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,109,371. The last known price of Bitcoin is 75,663.53857906 USD and is down -0.17 over the last 24 hours. It is currently trading on 12776 active market(s) with $9,277,191,640.33 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins sharp selloff and volatile trading have dominated discussion, with traders focused on whether key support will hold and pointing to leveraged liquidations as a possible driver. The community is split between calling the drop a buying opportunity or bear trap and expecting further downside; explanations tying it to geopolitical or Nvidia-related headlines remain speculative.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Reports of Nvidia CEO Jensen Huangs affair with a woman suspected of Chinese intelligence ties, and the resulting board probe, dominate discussion as traders debate potential governance and national-security risks and whether Nvidia weakness could weigh on the AI trade and broader market. Reactions are split between those bracing for further tech-led volatility and those dismissing the story as personal or already priced in.

Ethereum (ETH) is a cryptocurrency . Ethereum has a current supply of 122,197,894.00927157. The last known price of Ethereum is 2,232.83367397 USD and is down -0.19 over the last 24 hours. It is currently trading on 14283 active market(s) with $3,862,469,414.23 traded over the last 24 hours. More information can be found at https://www.ethereum.org/.

Ethereum

Ethereum is drawing attention amid a sharp crypto-wide selloff, with traders pointing to leveraged-long liquidations and weak broader risk sentiment; proposed macro and political causes remain speculation, with no clear ETH-specific catalyst established. Bears see further downside, while bulls are buying the dip and arguing the decline may be nearing a floor.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ discussion centers on volatility in megacap tech and AI, with traders weighing fears that Democratic gains could constrain data-center expansion and AI spending alongside reports about Nvidia CEO Jensen Huangs relationship with a woman suspected of Chinese intelligence ties. Bears see the AI trade unraveling, while dip buyers argue the headlines are overblown and point to sharp rebounds.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is drawing attention amid a sharp reversal in gold: traders linked an earlier bounce to post-election uncertainty and a softer dollar and yields, while stronger jobs data, a firmer dollar and renewed Fed-hike expectations have pressured prices. The community is split between dip buyers expecting gold to regain its safe-haven role and bears who see more downside and question that hedge status.

Stellar (XLM) is a cryptocurrency launched in 2014. Stellar has a current supply of 50,001,786,837.39707 with 35,372,680,256.2826 in circulation. The last known price of Stellar is 0.15097866 USD and is down -1.62 over the last 24 hours. It is currently trading on 848 active market(s) with $82,748,701.06 traded over the last 24 hours. More information can be found at https://www.stellar.org.

Stellar Lumens

XLMs persistent slide and repeated selling pressure are driving the conversation, with traders watching support levels and warning of further downside. Others view the pullback as a buying opportunity, while some bullish holders point to Stellars tokenization and institutional-partnership story but question whether adoption will translate into demand for the token.

Algorand (ALGO) is a cryptocurrency launched in 2019. Algorand has a current supply of 10,000,000,000 with 9,078,398,959.154897 in circulation. The last known price of Algorand is 0.09511009 USD and is down -1.88 over the last 24 hours. It is currently trading on 586 active market(s) with $50,888,027.03 traded over the last 24 hours. More information can be found at http://algorand.foundation.

Algorand

Algorands steep decline is prompting debate over whether recent weakness marks capitulation and a potential double-bottom bounce or whether the downtrend will continue. Some traders are accumulating the dip, while bears point to weak momentum and broader crypto-market vulnerability.

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Teva- Pharmaceutical Industries Ltd.

Teva- Pharmaceutical Industries Ltd. - ADR

Tevas quarterly results beat expectations and the company raised its outlook, with traders highlighting growth in innovative brands as a counterweight to pressure in generics. The reaction is broadly bullish, while traders are also watching the pending FDA decision on at-home Igalmi.

statis crypto Watchlist

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'Contract Awards'

Equity

No plague case has been confirmed, and no government orders have been announced, but outbreak-linked stocks jumped anyway.

Lakeland Industries (LAKE) Reports Q2 Loss, Tops Revenue Estimates

Lakeland Industries (LAKE) delivered earnings and revenue surprises of -340.00% and +4.46%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?

Lakeland Industries Q2 2027 Earnings Call: Complete Transcript

On Wednesday, Lakeland Industries (NASDAQ:LAKE) discussed second-quarter financial results during its earnings call. The full transcript is provided below.
This transcript is brought to you by Benzinga APIs. Forread more...

Stratasys (SSYS) Surpasses Q2 Earnings Estimates

Stratasys (SSYS) delivered earnings and revenue surprises of +200.00% and -1.56%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Resideo Technologies (REZI) Q2 Earnings and Revenues Top Estimates

Resideo Technologies (REZI) delivered earnings and revenue surprises of +22.06% and +2.45%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Kuehn Law Encourages Investors of Lakeland Industries, Inc. to Contact Law Firm

Kuehn Law Encourages Investors of Lakeland Industries, Inc. to Contact Law Firm Kuehn Law Encourages Investors of Lakeland Industries, Inc. to Contact Law Firm PR Newswire NEW YORK, July 21, 2026 NEW YORK, July 21, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is...

Is the Options Market Predicting a Spike in Lakeland Stock?

Investors need to pay close attention to (Ticker) stock based on the movements in the options market lately.

Lakeland Industries Q1 2027 Earnings Call: Complete Transcript

Lakeland Industries (LAKE) Beats Q1 Earnings Estimates

Lakeland Industries (LAKE) delivered earnings and revenue surprises of +128.57% and -3.04%, respectively, for the quarter ended April 2026. Do the numbers hold clues to what lies ahead for the stock?

Lakeland Industries (LAKE) Surges 12.6%: Is This an Indication of Further Gains?

Lakeland Industries (LAKE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Lakeland Industries, Inc. engages in the manufacture and sale of safety garments and accessories for the industrial and public protective clothing market. It operates through the Domestic and International geographical segments. The firm's products include disposable protective clothing, chemical protective clothing, woven protective clothing, fire protective gear, heat protective clothing, reflective protective clothing, hand and arm protection, arc or fire-retardant rated rainwear, and fire-retardant protective clothing. The company was founded in April 1982 and is headquartered in Huntsville, AL.

Lakeland Industries, Inc.

Neutral Sentiment

<ul class="summary-bullets"><li><a class="mention" data-mention="$NVAX" data-symbol-id="NVAX" href="https://stocktwits.com/symbol/NVAX" target="_blank">NVAX</a> surged 20%, EBS gained 14%, ARCT rose 13% and MRNA climbed 7% amid the Russian plague scare.</li><li>The rally broadened to protective-equipment, antiviral and immune-profiling stocks, with LAKE gaining 15% and APT and NNVC each rising 13%.</li><li>Russian authorities called the regional situation stable, while the WHO assessed the public risk as low.</li></ul>A Russian lab worker’s unexplained death&nbsp;in a plague research institute sparked a rally across vaccine and biodefense stocks on Monday, with Novavax (NVAX), Moderna (MRNA), Emergent BioSolutions (EBS) and Arcturus Therapeutics (ARCT) advancing as retail investors speculated about federal contracts and further gains.NVAX surged 20%,&nbsp;<a href="https://stocktwits.com/symbol/EBS">EBS</a> climbed 14%,&nbsp;<a href="https://stocktwits.com/symbol/ARCT">ARCT</a> gained 13% and&nbsp;<a href="https://stocktwits.com/symbol/MRNA">MRNA</a> rose 7%. Buying spread to protective-equipment suppliers, testing companies and antiviral developers as traders revived familiar outbreak bets.<img src="https://news.stocktwits-cdn.com/outbreak_rally_9d23a20745.png" alt="outbreak rally.png">The rally also extended to protective-equipment makers&nbsp;<a href="https://stocktwits.com/symbol/APT">Alpha Pro Tech (APT)</a>, which rose 13% on Monday, and&nbsp;<a href="https://stocktwits.com/symbol/LAKE">Lakeland Industries (LAKE)</a>, which gained 15%. Antiviral developer&nbsp;<a href="https://stocktwits.com/symbol/NNVC">NanoViricides (NNVC)</a> climbed 13%, immune-profiling company&nbsp;<a href="https://stocktwits.com/symbol/VRAX">Virax Biolabs (VRAX)</a> advanced 10%, and smallpox-drug maker&nbsp;<a href="https://stocktwits.com/symbol/SIGA">Siga Technologies (SIGA)</a> added 3%.&nbsp;Cancer-immunotherapy developer&nbsp;<a href="https://stocktwits.com/symbol/IBRX">ImmunityBio (IBRX)</a>, which also featured in retail discussions about government demand, edged up 1%.&nbsp;&nbsp;<h2 class="st-heading-2">Trump’s Russia Offer Fuels Spending Hopes</h2>“We’ll help,” Trump said on Monday, calling the situation a “big problem for Russia,” Reuters&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/world/us/trump-says-us-will-help-russia-after-siberia-plague-institute-death-2026-10-05/">reported</a>. The remarks came after the death of Darya Shipilova, a 28-year-old lab technician at the Irkutsk Anti-Plague Research Institute in Siberia. She developed pneumonia of unknown origin, prompting quarantine measures and medical observation of people who had contact with her.Russia’s public health agency, Rospotrebnadzor, said samples contained no microorganisms associated with her professional duties and called the regional epidemiological situation stable.&nbsp;The WHO said that the risk to the general population appeared low based on available unofficial information. U.S. Secretary of State Marco Rubio also urged measured attention, calling the situation a “cause for focus,” according&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edition.cnn.com/2026/10/05/world/video/rubio-says-situation-in-russia-is-cause-for-focus-but-not-alarm">to</a> CNN.The uncertainty nevertheless gave traders a familiar catalyst: the prospect that heightened preparedness could lead to government purchases.<h2 class="st-heading-2">Vaccine Makers Ride Outbreak Bets</h2>Novavax, Moderna and Arcturus have commercial vaccines, but their products do not target plague. Novavax developed Nuvaxovid, a protein-based COVID-19 vaccine containing its Matrix-M adjuvant. Matrix-M enhances immune responses and can be incorporated into other vaccines, giving the company broader vaccine-development and licensing exposure.Moderna markets COVID-19 vaccines, including Spikevax, and the RSV vaccine mRESVIA. Its mRNA tech makes it a familiar name in emerging-pathogen trades.&nbsp;Meanwhile, Arcturus has the commercial COVID-19 vaccine Kostaive and is developing ARCT-2304, an experimental H5N1 pandemic-influenza vaccine. BARDA fully funds the candidate’s Phase 1 study.<h2 class="st-heading-2">Stockpile Suppliers And PPE Makers Rally</h2>Emergent has a direct connection to government purchasing through its medical-countermeasure portfolio. BioThrax and Cyfendus are anthrax vaccines, while ACAM2000 is a smallpox and mpox vaccine. Tembexa, another portfolio product, is a smallpox antiviral. Its $24 million BARDA contract modification for Cyfendus, announced last month, shows its procurement model.&nbsp;Siga supplies TPOXX, a smallpox antiviral, to the Strategic National Stockpile. Lakeland and Alpha Pro Tech provide protective equipment. Lakeland supplies protective clothing, while Alpha Pro Tech manufactures disposable garments, masks and face shields.&nbsp;<h2 class="st-heading-2">Antiviral And Immunotherapy Names Join Rally</h2>Virax Biolabs focuses on immune-response detection and T-cell profiling, including applications in post-acute infection syndromes such as Long COVID. NanoViricides is developing NV-387, an antiviral drug candidate. Because plague is bacterial, its rally reflects broader outbreak sentiment rather than an established plague-treatment opportunity.Meanwhile, ImmunityBio markets Anktiva, a cancer immunotherapy, and develops immune-cell platforms.<h2 class="st-heading-2">How Do Retail Traders Feel About Outbreak Bets?</h2>On Stocktwits, retail sentiment for NVAX and EBS was ‘extremely bullish’ amid ‘extremely high’ message volume. ARCT drew ‘bullish’ sentiment with ‘normal’ chatter, while MRNA sentiment remained ‘neutral’ despite ‘high’ message volume.&nbsp;One user on EBS&nbsp;<a href="https://stocktwits.com/KnuckleSandwich/message/665783238">said</a>: “Contract awards are in bound....good timing with the Russia plague news fueling the momentum!!” The user added: “See you at 15++.. Might even hit 20 by year-end!” Another user on NVAX&nbsp;<a href="https://stocktwits.com/TobySmith1366/message/665803930">sees</a> a return to “operation warp speed” and “throwing billions at NVAX.”One user on APT&nbsp;<a href="https://stocktwits.com/Paretoprincipal/message/665752847">drew parallels</a> with a previous outbreak trade: “Hantavirus took APT from $4.50 to $7.50 this May. The plague should take us even higher.” Another user on NNVC&nbsp;<a href="https://stocktwits.com/insanitywolftrading/message/665786543">noted</a> that “every time there is a pandemic fear this makes a massive run.”So far this year, NVAX has gained 87%, MRNA has surged 589% and ARCT has climbed 139%, while EBS remains down 41%.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/spcx-stock-musk-trillionaire-sequoia-maguire-investors-starting-to-understand-spacex/cZDsnwARBjv">SPCX Stock Makes Musk A Trillionaire Again: Sequoia's Maguire Says Investors Are Just 'Starting To Understand SpaceX'&nbsp;</a>

Alpha Pro Tech Ltd.

Arcturus Therapeutics Holdings Inc

Emergent Biosolutions Inc

ImmunityBio Inc

Moderna Inc

NanoViricides Inc

Novavax Inc

SIGA Technologies Inc

Virax Biolabs Group Ltd

SPDR S&P Biotech ETF

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$8.95
Prev Close	$8.94
Open	$8.78
Dividend Yield	1.27%
50-Day Moving Average	$10.10
Beta	1.06
Avg. Volume	119,093.55
PE Ratio	-3.28

52-Week High	$16.91
52-Week Low	$7.15
Market Capitalization	$88.89M
EPS (Annual)	-$2.63
Price to Book	0.71
Revenue Per Employee	$74,095.38

Feed

News

Sentiment

Earnings

Fundamentals

Info

LAKE Fundamentals